MARK PASSOW: Open Payments
NPI 1871908897 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 28 payments from 16 companies in 2025. Trend: 2023 $778 · 2024 $555 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 6 | $139 |
| ABBVIE INC. | 3 | $73 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| Novo Nordisk Inc | 2 | $52 |
| Orexo US, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Exact Sciences Corporation | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: SUBLOCADE, VRAYLAR, AUSTEDO XR, Ozempic, Zubsolv, INGREZZA, CAPLYTA, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
